US · Healthcare

Anthera Pharmaceuticals Inc (ANTH)

Biotechnology

Anthera Pharmaceuticals Inc (ANTH) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ANTH

P/E ratio

25.00

Anthera Pharmaceuticals Inc (ANTH) — FAQ

What is ANTH's P/E ratio?

The price-to-earnings (P/E) ratio for Anthera Pharmaceuticals Inc (ANTH) is 25.00 (data as of 2026-05-23).

Does Anthera Pharmaceuticals Inc pay a dividend?

Dividend yield is not available in the current snapshot for Anthera Pharmaceuticals Inc (ANTH). Check the MyAverix Finance app for the latest dividend data.

What sector is Anthera Pharmaceuticals Inc in?

Anthera Pharmaceuticals Inc (ANTH) is classified in the Healthcare sector (Biotechnology industry).

What exchange is ANTH listed on?

ANTH is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)